MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2020.106518

Медицинская библиотека · International immunopharmacology · 2020

Mitochondrial-targeted ubiquinone alleviates concanavalin A-induced hepatitis via immune modulation.

Desta Yemane Tadesse, Wu Mi, Bai Li, Wu Xiongwen, Xiong Min, Weng Xiufang

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Despite knowledge regarding the effects of antioxidants in ameliorating oxidative damage, evidence concerning their effects on activated immune cells is lacking. Here, a concanavalin A (Con A)-induced hepatitis mouse model was used to investigate the protective effects and immune regulatory mechanisms of mitochondrial-targeted ubiquinone (MitoQ).

METHODS

Wild-type (WT) and CD1d-knockout (CD1d-/-, NKT cell deficient) mice were pretreated with MitoQ and then intravenously injected with a sublethal dose of Con A. Serum transaminase and inflammatory cytokine levels were tested. Immune cell functions and AMPK/mTORC1 pathway activation in liver tissue were also evaluated.

RESULTS

NKT cells were critical for extensive pro-inflammatory cytokine production and prolonged liver injury upon Con A challenge, while IFN-γ-producing non-NKT cells played an important role during the hyperacute phase. MitoQ treatment not only ameliorated NKT cell-independent hyperacute hepatitis within 12 h post Con A administration but also alleviated NKT cell-dependent extended liver injury at 24 h. The underlying mechanisms involved an inhibition of the heightened activation of iNKT cells and conventional T cells, suppression of the excessive production of IFN-γ, TNF-α and IL-6, and modulation of aberrant AMPK and mTORC1 pathways.

CONCLUSION

MitoQ efficiently alleviates Con A-induced hepatitis through immune regulation, suggesting a new therapeutic approach for immune-mediated liver injury by targeting mitochondrial ROS.

Для цитирования: Desta Yemane Tadesse, Wu Mi, Bai Li, Wu Xiongwen, Xiong Min, Weng Xiufang. Mitochondrial-targeted ubiquinone alleviates concanavalin A-induced hepatitis via immune modulation.. International immunopharmacology. 2020. DOI: 10.1016/j.intimp.2020.106518.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.